The CCL22 gene helps guide immune cells, especially certain white blood cells called T cells, to places where the body needs an immune response. If it does not work as expected, immune signals may become less balanced, which can affect inflammation and may play a role in allergy related conditions. This gene plays an important role in helping the immune system respond to germs while also keeping some reactions from becoming too strong. Most variants in the CCL22 gene are not known to cause a single inherited condition on their own.
What is a gene?
Genes are sections of DNA that give your cells instructions for making molecules or managing activities in the body. Some genes carry the information needed to make proteins, the parts of cells that do the work. Other genes mainly regulate when certain processes happen, where they happen, and how strongly they operate. Together, genes affect how the body develops and works, and they can also influence how you respond to food, stress, or medications. To explore this subject in greater depth, you can read more in the LearnHub.
Overview
CCL22Gene function
What if the gene works
The CCL22 gene helps make a signaling protein that attracts certain immune cells. This helps direct immune cells to lymph nodes and inflamed tissues and supports balanced immune responses.
Risk
What if the gene does not work
Changes in the CCL22 gene can range from milder to more severe variants. These changes may reduce or alter the CCL22 signal that helps guide immune cells, especially certain T cells, changing how cells move and communicate.
Treatment
What does that mean for your treatment
No CCL22-specific treatment or management approach is currently established for a pathogenic or loss-of-function variant in the CCL22 gene. In research, CCL22 is being studied mainly as an immune signaling biomarker and as part of the CCR4 pathway, which may help guide future therapies in some cancers and inflammatory conditions.
Gene function
What if the gene works
In everyday immune function, the CCL22 gene helps certain white blood cells reach the right place at the right time. Its protein creates a chemical trail that nearby immune cells can follow. This steady movement supports tissue patrol and organized communication between immune cells.
The CCL22 gene makes a signal protein that attracts certain white blood cells. It helps cells carrying the CCR4 receptor move toward tissues or immune hubs where they are needed.
This signal especially helps direct some T cells, including cells that help keep immune reactions measured. By bringing these cells to the right place, the body can coordinate local immune activity more smoothly.
Its protein acts as a chemokine, a small messenger that gives immune cells movement cues. That signaling is a central part of the CCL22 gene's role in the immune system.
What is a variant?
A genetic variant is a minor difference in the DNA sequence within a gene. These differences are common and are part of normal human variation, including differences in appearance, metabolism, or the way the body responds to environmental influences. Many variants do not cause any noticeable effects and simply represent natural genetic diversity. In some situations, though, a variant can change how a gene works to a greater extent and may contribute to, or directly cause, a genetic condition.
Genetic variants
What if the gene does not work
Changes in the CCL22 gene can alter how much CCL22 protein a cell makes or releases, which is the main way CCL22 gene variants affect protein function. Some variants may subtly change the protein’s shape and weaken its binding to its receptor, while more disruptive variants can greatly reduce protein stability, secretion, or signaling. This severity range can lead to milder or stronger effects at the cellular level rather than one fixed outcome.
How variants are linked to conditions
Current evidence on how variants of the CCL22 gene are linked to conditions is still developing, and this gene does not yet have a broadly confirmed link to one specific health condition. If you carry a reported change in the CCL22 gene, your own results are best interpreted with your doctor or genetic counselor, especially when family history or other test findings are part of the picture.
A variant is not necessarily a diagnosis
Variants in DNA are a routine part of being human and are widespread across the population. Most do not directly affect health and simply reflect normal human variation. For many genes, having a variant associated with a condition points to a possible link rather than a certain diagnosis, particularly when more than one gene and environmental influences play a role. Still, in some situations, one well-studied variant in a particular gene is enough to establish a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the CCL22 gene. Many effects linked with CCL22 appear to depend on the bigger picture, including other genes, immune activity, and everyday environmental exposures, so personal risk is best discussed with a doctor or genetic counselor.
Inheritance of CCL22 variants
There is not yet a broadly confirmed Mendelian pattern for the inheritance of CCL22 gene variants tied to a specific inherited condition. In most people, discussion of CCL22 changes relates more to research findings or risk links than to a clearly defined dominant, recessive, or X linked syndrome. The CCL22 gene is located on chromosome 16, which is an autosome, so you inherit one copy from each parent. In that sense, the inheritance of CCL22 gene variants follows the usual pattern for autosomal genes, with either parent able to pass a variant to a child.
What does my CCL22 result mean for my family?
There is not yet a broadly confirmed inherited pattern linking CCL22 to a specific genetic condition in families, though this can change as research grows. If you have a specific CCL22 result and want to understand what it could mean for relatives, a doctor or genetic counselor can explain it in the context of your personal and family history.
Genetic information
Genetic testing
How you find out about variants
Variants in the CCL22 gene are usually found through genetic testing that reads DNA from a blood, saliva, or cheek swab sample, often alongside other genes or with broader DNA reading. Genetic testing for CCL22 variants compares your DNA code with a reference sequence to look for changes, then a lab classifies any variant using current evidence.
When should I consider getting a genetic test?
There is not yet a broadly established reason to test the CCL22 gene on its own in routine care. Decisions about genetic testing are usually based on your personal health history, symptoms, and family history, together with a doctor or genetic counselor.
A genetic result is only one part of your health story
A genetic result can be informative, but how much it reveals depends on the condition and the kind of variant involved. Over time, many factors, including lifestyle, environment, age, and medical history, influence how the body works. For some conditions, especially those shaped by many genes, genetic information offers context rather than certainty and is best considered alongside other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, genetic results can also help put individual experiences into perspective.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body responds to medicines. This helps explain why the same medication may work well for one person, have less effect in another, or cause more side effects in someone else. Differences in how the body absorbs, breaks down, transports, or reacts to a drug are common, and they can influence both treatment benefit and sensitivity.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences affect the way people respond to medications. It looks at connections between genes and drugs to better understand why the same treatment may work differently from one person to another. For many medicines, genes influence how strongly a drug works or how the body handles it. This information can support more informed, individualized treatment decisions. More about this topic is available in the LearnHub.
Drugs influenced by the CCL22 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication response, so questions about symptoms, treatment side effects, or the best medicine for you are best discussed with your doctor or pharmacist.
History
First described in the scientific literature as part of early genetics, the CCL22 gene came to attention in the late 1990s during a wave of research on immune signaling molecules called chemokines. It was initially identified through studies of immune cells and was first known as macrophage derived chemokine, or MDC. As medical science evolved, so did understanding of this gene, and standardized naming placed it within the CC chemokine family as CCL22. Early work helped distinguish it from closely related signaling genes that had been grouped together before naming systems became more consistent. From these first observations, research expanded steadily, especially in allergy, inflammation, and cancer immunology. This historical path reflects how many immune genes moved from descriptive lab names to a clearer place in modern genetics.